• Category: Business
Leadership watch: OKYO, Orbis, and BVI Medical name new CEOs
Business

Leadership watch: OKYO, Orbis, and BVI Medical name new CEOs

Leadership changes are underway in the eyecare space—and we’ve got the latest.
Newton names ABB Labs as strategic lab partner
Business

Newton names ABB Labs as strategic lab partner

Collaboration leverages the largest independent optical laboratory network in the U.S. to bring Neurolens and Sequel lens technologies to more practices.
Topcon and RemoniHealth to advance AI-based chronic eye disease monitoring
Business

Topcon and RemoniHealth to advance AI-based chronic eye disease monitoring

New partnership will integrate remote at-home vision testing with Topcon’s connected care model to support ongoing Healthcare from the Eye initiative.
Nanodropper now operating as Mu Medical, a precision eyecare platform
Business

Nanodropper now operating as Mu Medical, a precision eyecare platform

Developer of the volume-reducing eye drop bottle adaptor consolidates with Bedo Solutions and Viseon Labs into a commercial-stage medtech ecosystem.
STAAR Surgical and Alcon terminate proposed merger
Business

STAAR Surgical and Alcon terminate proposed merger

Decision to end the estimated $1.6 billion deal follows a failed vote among STAAR stockholders earlier this week.
Alcon proposes higher bid for STAAR Surgical acquisition
Business

Alcon proposes higher bid for STAAR Surgical acquisition

Amended merger agreement increases total equity value of deal by $150 million; meanwhile, a major shareholder is urging against the sale.
Leadership watch: Prevent Blindness, SightGlass, and Meibum Scientific share updates
Business

Leadership watch: Prevent Blindness, SightGlass, and Meibum Scientific share updates

Industry changes are underway in the eyecare space—and we’ve got the latest.
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants
Business

Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants

Collaboration involves the Epidel prodrug platform, which engineers polymer-free drugs with customized, repeat doses and durations for ophthalmic diseases.
Harrow officially acquires Melt Pharmaceuticals
Business

Harrow officially acquires Melt Pharmaceuticals

Purchase includes portfolio non-IV, opioid-free tablets—including MELT-300, under clinical evaluation for procedural sedation during cataract surgery.
TearOptix secures funding for presbyopia MF lens tech
Business

TearOptix secures funding for presbyopia MF lens tech

Company is developing a tear-and-blink-responsive contact lens technology utilizing tear film dynamics to work with the eye’s natural physiology.
iOR Partners launches MD-OD surgery partnership model
Business

iOR Partners launches MD-OD surgery partnership model

First-of-its-kind collaboration is designed to create a streamlined continuum of care for all patients, pivoting to a primarily cash-based system.
Leadership watch: New appointments at EOE, OWL, and EyeCool
Business

Leadership watch: New appointments at EOE, OWL, and EyeCool

Leadership changes are underway in the eyecare space—and we’ve got the latest.
Newton acquires Founders Optical Lab
Business

Newton acquires Founders Optical Lab

Independent optical lab offers ECPs a curated selection of lens designs manufactured in-house from top brands such as Sequel, Neurolens, and others.
Eyes On Eyecare accelerates growth with new leadership appointment
Business

Eyes On Eyecare accelerates growth with new leadership appointment

Leading eyecare digital media and education platform welcomes Rachel Krug as vice president of Sales.
LambdaVision raises $7M to advance space-based artificial retina
Business

LambdaVision raises $7M to advance space-based artificial retina

Biotech is using space and microgravity to produce its protein-based artificial retina, designed to restore vision in retinal degenerative diseased patients.
AOAExcel endorses VisionHQ's in-office patient membership plans
Business

AOAExcel endorses VisionHQ's in-office patient membership plans

Platform offers optometric practices in-house, customizable membership and subscription plans in lieu of traditional vision insurance for patients.
DefEYE and Celularity partner to advance ophthalmic biologics portfolios
Business

DefEYE and Celularity partner to advance ophthalmic biologics portfolios

Collaboration features a multi-million dollar investment in DefEYE as well as an exclusive sublicense of Celularity’s BIOVANCE amnion-derived ocular allografts.
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Business

Smartlens raises $5.2 million to advance miLens FDA clearance and launch

Financing to support the ongoing advancement and FDA clearance process of the miLens, an electronics-free contact lens technology.
Lilly to purchase Adverum Biotechnologies
Business

Lilly to purchase Adverum Biotechnologies

With a Q4 closing date in mind, acquisition supports ongoing clinical trials and development activities for Ixo-vec, a one-time IVT gene therapy injection to treat wet AMD.
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Business

Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device

Upcoming clinical trials to study the Intercil Uveal Spacer, a cilioscleral interpositioning device that reestablishes the natural uveoscleral outflow.